1Lytsy P,Lind L,Sundstrom J.Endothelial function and risk of hypertension and blood pressure progression:the prospective investigation of the vasculature in Uppsala seniors[J].J Hypertens,2013;31(5):936-9.
2Ahmed LA,Obaid AA,Zaki HF,et al.Role of oxidative stress,inflammation,nitric oxide and transforming growth factor-beta in the protective effect of diosgenin in monocrotaline-induced pulmonary hypertension in rats[J].Eur J Pharmacol,2014;740(4):379-87.
3Solun B,Marcoviciu D,Dicker D.Dipeptidyl peptidase-4 inhibitors and their effects on the cardiovascular system[J].Curr Cardiol Rep,2013;15(8):1-8.
4Lorber D.GLP-1 receptor agonists:effects on cardiovascular risk reduction[J].Cardiovasc Ther,2013,18(31):238-249.
5Katout M,Zhu H,Rutsky J,et al.Effect of GLP-1 mimetics on blood pressure and relationship to weight loss and glycemic lowering:results of a systematic meta-analysis and meta-regression[J].Am J Hypertens,2014,330(27):130-139.
6Neal B,Perkovic V,de Zeeuw D,et al.Rationale,design,and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study(CANVAS)-a randomized placebocontrolled trial[J].Am Heart J,2013,27(166):227.
